A new era in the treatment of migraine headache arrived with development of a revolutionary class of drugs known as the triptans.

The book describes the development of this class of drugs, starting with the discovery of sumatriptin, covers the pharmacology and the mechanisms of action of the full range of triptans, before comparing their clinical efficacy and tolerability. Each drug is described by the company who produces it and then reviewed, based on experimental and clinical evidence, by independent scientists.

This comprehensive review will provide clinicians with guidance on which triptan to select for which patient.

The editors have gathered together the leading international experts to produce a book that will appeal to all neurologists and general physicians caring for headache patients as well as those with research interests in the field.